296 related articles for article (PubMed ID: 29625583)
1. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.
Linsenmeier L; Mohammadi B; Wetzel S; Puig B; Jackson WS; Hartmann A; Uchiyama K; Sakaguchi S; Endres K; Tatzelt J; Saftig P; Glatzel M; Altmeppen HC
Mol Neurodegener; 2018 Apr; 13(1):18. PubMed ID: 29625583
[TBL] [Abstract][Full Text] [Related]
2. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
4. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
5. Shedding light on prion disease.
Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
Prion; 2015; 9(4):244-56. PubMed ID: 26186508
[TBL] [Abstract][Full Text] [Related]
6. Role of redox-sensitive catalytic interaction with ADAM10 in mutant-selective extracellular shedding of prion protein.
Shin Y; Jo KS; Shin M; Lee D; Yeo H; Song Y; Kang SW
Redox Biol; 2022 Oct; 56():102456. PubMed ID: 36041363
[TBL] [Abstract][Full Text] [Related]
7. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts.
Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC
Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701
[TBL] [Abstract][Full Text] [Related]
8. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
9. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
10. Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies.
Linsenmeier L; Mohammadi B; Shafiq M; Frontzek K; Bär J; Shrivastava AN; Damme M; Song F; Schwarz A; Da Vela S; Massignan T; Jung S; Correia A; Schmitz M; Puig B; Hornemann S; Zerr I; Tatzelt J; Biasini E; Saftig P; Schweizer M; Svergun D; Amin L; Mazzola F; Varani L; Thapa S; Gilch S; Schätzl H; Harris DA; Triller A; Mikhaylova M; Aguzzi A; Altmeppen HC; Glatzel M
Sci Adv; 2021 Nov; 7(48):eabj1826. PubMed ID: 34818048
[TBL] [Abstract][Full Text] [Related]
11. The Role of Shed PrP
Megra BW; Eugenin EA; Berman JW
J Immunol; 2017 Jul; 199(1):224-232. PubMed ID: 28533442
[TBL] [Abstract][Full Text] [Related]
12. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
13. Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease.
Callender JA; Sevillano AM; Soldau K; Kurt TD; Schumann T; Pizzo DP; Altmeppen H; Glatzel M; Esko JD; Sigurdson CJ
Neurobiol Dis; 2020 Aug; 142():104955. PubMed ID: 32454127
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
15. Diverse functions of the prion protein - Does proteolytic processing hold the key?
Linsenmeier L; Altmeppen HC; Wetzel S; Mohammadi B; Saftig P; Glatzel M
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2128-2137. PubMed ID: 28693923
[TBL] [Abstract][Full Text] [Related]
16. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo.
Altmeppen HC; Prox J; Puig B; Kluth MA; Bernreuther C; Thurm D; Jorissen E; Petrowitz B; Bartsch U; De Strooper B; Saftig P; Glatzel M
Mol Neurodegener; 2011 May; 6():36. PubMed ID: 21619641
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15.
Seipold L; Altmeppen H; Koudelka T; Tholey A; Kasparek P; Sedlacek R; Schweizer M; Bär J; Mikhaylova M; Glatzel M; Saftig P
Cell Mol Life Sci; 2018 Sep; 75(17):3251-3267. PubMed ID: 29520422
[TBL] [Abstract][Full Text] [Related]
18. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.
Ostapchenko VG; Beraldo FH; Guimarães AL; Mishra S; Guzman M; Fan J; Martins VR; Prado VF; Prado MA
J Neurochem; 2013 Nov; 127(3):415-25. PubMed ID: 23651058
[TBL] [Abstract][Full Text] [Related]
19. Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.
Chen C; Lv Y; Zhang BY; Zhang J; Shi Q; Wang J; Tian C; Gao C; Xiao K; Ren K; Zhou W; Dong XP
Mol Neurobiol; 2014 Dec; 50(3):875-87. PubMed ID: 24771043
[TBL] [Abstract][Full Text] [Related]
20. TREM2 expression in the brain and biological fluids in prion diseases.
Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
